{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T12:49:17Z","timestamp":1785761357263,"version":"3.56.0"},"reference-count":32,"publisher":"Walter de Gruyter GmbH","issue":"4","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Handling clinical samples from patients suspected of SARS-CoV-2 infection puts healthcare workers at risk of exposure to infectious particles. To reduce this risk, samples are often heat-inactivated before nucleic acid isolation, but this procedure may affect the analytical sensitivity of the test. The aim of this study was therefore to evaluate the effects of heat inactivation (56 \u00b0C for 30 min) on RT-qPCR results of samples taken from nasopharyngeal and oropharyngeal (NP\/OP) swabs collected from 200 symptomatic patients. Each sample was split into two aliquots \u2013 one subjected to heat inactivation and the other stored at 4 \u00b0C \u2013 followed by nucleic acid isolation and RT-qPCR analysis using the GeneFinder COVID-19 nucleic acid test. Heat inactivation did not significantly affect the overall SARS-CoV-2 detection rate (55.5 % vs. 55.0 % in untreated and heat-treated groups; \u03c7\n                    <jats:sup>2<\/jats:sup>\n                    =0.01; p=0.91). However, discrepancies occurred in 15.3 % of samples, all with quantification cycle (Cq) values &gt;31, including target loss, gain, or complete signal disappearance after heat treatment. Heat inactivation also slightly decreased Cq values for the RNA-dependent RNA polymerase (\n                    <jats:italic>RdRp<\/jats:italic>\n                    ) and envelope (\n                    <jats:italic>E<\/jats:italic>\n                    ) genes and increased those for the nucleocapsid (\n                    <jats:italic>N<\/jats:italic>\n                    ) gene, with significant changes in strongly positive samples (Cq\u226433). In positive samples (Cq\u226440), the human ribonuclease (\n                    <jats:italic>RNase<\/jats:italic>\n                    ) P gene also exhibited significantly higher Cq values after heat treatment. In the strongly positive subgroup, correlation analysis showed moderate correlation for\n                    <jats:italic>RdRp<\/jats:italic>\n                    and very strong correlation for the\n                    <jats:italic>N<\/jats:italic>\n                    and\n                    <jats:italic>E<\/jats:italic>\n                    genes, and a weaker correlation for weakly positive samples. In conclusion, heat inactivation at 56 \u00b0C for 30 min does not significantly affect viral gene detection but may diminish it in samples with low viral load.\n                  <\/jats:p>","DOI":"10.2478\/aiht-2025-76-3973","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T05:04:44Z","timestamp":1767675884000},"page":"242-250","source":"Crossref","is-referenced-by-count":0,"title":["The impact of heat inactivation on RT-qPCR detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): an experience from the University Clinical Centre of Vojvodina, Serbia"],"prefix":"10.2478","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9962-0810","authenticated-orcid":false,"given":"Jelena Stoj\u010devi\u0107","family":"Maleti\u0107","sequence":"first","affiliation":[{"name":"University of Novi Sad Faculty of Medicine , Novi Sad , Serbia"},{"name":"University Clinical Centre of Vojvodina , Novi Sad , Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iva","family":"Barjaktarovi\u0107","sequence":"additional","affiliation":[{"name":"University of Novi Sad Faculty of Medicine , Novi Sad , Serbia"},{"name":"University Clinical Centre of Vojvodina , Novi Sad , Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ljiljana","family":"Andrijevi\u0107","sequence":"additional","affiliation":[{"name":"University of Novi Sad Faculty of Medicine , Novi Sad , Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina","family":"Ba\u010dulov","sequence":"additional","affiliation":[{"name":"University of Novi Sad Faculty of Medicine , Novi Sad , Serbia"},{"name":"University Clinical Centre of Vojvodina , Novi Sad , Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Slobodanka","family":"Bogdanovi\u0107 Vasi\u0107","sequence":"additional","affiliation":[{"name":"\u0160abac Academy of Vocational Studies , \u0160abac , Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diandra Pinta\u0107","family":"\u0160arac","sequence":"additional","affiliation":[{"name":"University of Novi Sad Faculty of Medicine , Novi Sad , Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2025,12,30]]},"reference":[{"key":"2026080312015329668_j_aiht-2025-76-3973_ref_001","doi-asserted-by":"crossref","unstructured":"She J, Jiang J, Ye L, Hu L, Bai C, Song Y. 2019 novel coronavirus of pneumonia in Wuhan, China: emerging attack and management strategies. Clin Transl Med 2020;9(1):19. doi: 10.1186\/s40169-020-00271-z","DOI":"10.1186\/s40169-020-00271-z"},{"key":"2026080312015329668_j_aiht-2025-76-3973_ref_002","doi-asserted-by":"crossref","unstructured":"Zanke AA, Thenge RR, Adhao VS. COVID-19: A pandemic declare by world health organization. IP Int J Compr Adv Pharmacol 2020;5:49\u201357. doi: 10.18231\/j.ijcaap.2020.012","DOI":"10.18231\/j.ijcaap.2020.012"},{"key":"2026080312015329668_j_aiht-2025-76-3973_ref_003","unstructured":"World Health Organization (WHO). Coronavirus disease (COVID-19) dashboards [displayed 24 December 2024]. Available at https:\/\/data.who.int\/dashboards\/covid19\/cases"},{"key":"2026080312015329668_j_aiht-2025-76-3973_ref_004","doi-asserted-by":"crossref","unstructured":"Esbin MN, Whitney ON, Chong S, Maurer A, Darzacq X, Tjian R. Overcoming the bottleneck to widespread testing: a rapid review of nucleic acid testing approaches for COVID-19 detection. RNA 2020;26:771\u201383. doi: 10.1261\/rna.076232.120","DOI":"10.1261\/rna.076232.120"},{"key":"2026080312015329668_j_aiht-2025-76-3973_ref_005","unstructured":"World Health Organization (WHO). Advice on the use of point-of-care immunodiagnostic tests for COVID-19 [displayed 24 December 2024]. Available at https:\/\/www.who.int\/news-room\/commentaries\/detail\/advice-on-the-use-of-point-of-care-immunodiagnostic-tests-for-covid-19"},{"key":"2026080312015329668_j_aiht-2025-76-3973_ref_006","doi-asserted-by":"crossref","unstructured":"Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, Bleicker T, Br\u00fcnink S, Schneider J, Schmidt ML, Mulders DG, Haagmans BL, van der Veer B, van den Brink S, Wijsman L, Goderski G, Romette JL, Ellis J, Zambon M, Peiris M, Goossens H, Reusken C, Koopmans MP, Drosten C. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill 2020;25(3):2000045. doi: 10.2807\/1560-7917.ES.2020.25.3.2000045","DOI":"10.2807\/1560-7917.ES.2020.25.3.2000045"},{"key":"2026080312015329668_j_aiht-2025-76-3973_ref_007","doi-asserted-by":"crossref","unstructured":"Kumar R, Nagpal S, Kaushik S, Mendiratta S. COVID-19 diagnostic approaches: different roads to the same destination. Virus Dis 2020;31:97\u2013105. doi: 10.1007\/s13337-020-00599-7","DOI":"10.1007\/s13337-020-00599-7"},{"key":"2026080312015329668_j_aiht-2025-76-3973_ref_008","doi-asserted-by":"crossref","unstructured":"Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL, Vandesompele J, Wittwer CT. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 2009;55:611\u201322. doi: 10.1373\/clinchem.2008.112797","DOI":"10.1373\/clinchem.2008.112797"},{"key":"2026080312015329668_j_aiht-2025-76-3973_ref_009","doi-asserted-by":"crossref","unstructured":"Bustin SA, Ruijter JM, van den Hof MJBf, Kubista M, Pfaffl MW, Shipley GL, R\u00f6diger NTS, Untergasser A, Mueller R, Nolan T, Milavec M, Burns MJ, Huggett JF, Vandesompele J, WittwerCT. MIQE 2.0: revision of the minimum information for publication of quantitative real-time PCR experiments guidelines. Clin Chem 2025;71:634\u201351. doi: 10.1093\/clinchem\/hvaf043","DOI":"10.1093\/clinchem\/hvaf043"},{"key":"2026080312015329668_j_aiht-2025-76-3973_ref_010","doi-asserted-by":"crossref","unstructured":"Chang CK, Hou MH, Chang CF, Hsiao CD, Huang TH. The SARS coronavirus nucleocapsid protein--forms and functions. Antiviral Res 2014;103:39\u201350. doi: 10.1016\/j.antiviral.2013.12.009","DOI":"10.1016\/j.antiviral.2013.12.009"},{"key":"2026080312015329668_j_aiht-2025-76-3973_ref_011","unstructured":"National Center for Biotechnology Information. ORF1ab ORF1a polyprotein;ORF1ab polyprotein [Severe acute respiratory syndrome coronavirus 2]. Gene ID: 43740578 [displayed 24 December 2024]. Available at https:\/\/www.ncbi.nlm.nih.gov\/gene\/43740578"},{"key":"2026080312015329668_j_aiht-2025-76-3973_ref_012","doi-asserted-by":"crossref","unstructured":"Alanagreh L, Alzoughool F, Atoum M. The human coronavirus disease COVID-19: its origin, characteristics, and insights into potential drugs and its mechanisms. Pathogens 2020;9:331. doi: 10.3390\/pathogens9050331","DOI":"10.3390\/pathogens9050331"},{"key":"2026080312015329668_j_aiht-2025-76-3973_ref_013","unstructured":"Centers for Disease Control and Prevention - CDC 2019-novel coronavirus (2019-nCoV) real-time RT-PCR diagnostic panel [displayed 24 December 2024]. Available at https:\/\/www.fda.gov\/media\/134922\/download"},{"key":"2026080312015329668_j_aiht-2025-76-3973_ref_014","doi-asserted-by":"crossref","unstructured":"Kim HN, Yoon S-Y, Lim CS, Yoon J. Comparison of three molecular diagnostic assays for SARS-CoV-2 detection: Evaluation of analytical sensitivity and clinical performance. J Clin Lab Anal 2022;36:e24242. doi: 10.1002\/jcla.24242","DOI":"10.1002\/jcla.24242"},{"key":"2026080312015329668_j_aiht-2025-76-3973_ref_015","unstructured":"World Health Organization (WHO). Laboratory biosafety guidance related to the novel coronavirus (2019-nCoV) [displayed 24 December 2024]. Available at https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/laboratory-biosafety-novel-coronavirus-version-1-1.pdf"},{"key":"2026080312015329668_j_aiht-2025-76-3973_ref_016","doi-asserted-by":"crossref","unstructured":"Bat\u00e9jat C, Grassin Q, Manuguerra JC, Leclercq I. Heat inactivation of the severe acute respiratory syndrome coronavirus 2. J Biosaf Biosecur 2021;3:1\u20133. doi: 10.1016\/j.jobb.2020.12.001","DOI":"10.1016\/j.jobb.2020.12.001"},{"key":"2026080312015329668_j_aiht-2025-76-3973_ref_017","doi-asserted-by":"crossref","unstructured":"Auerswald H, Yann S, Dul S, In S, Dussart P, Martin NJ, Karlsson EA, Garcia-Rivera JA. Assessment of inactivation procedures for SARS-CoV-2. J Gen Virol 2021;102(3):001539. doi: 10.1099\/jgv.0.001539","DOI":"10.1099\/jgv.0.001539"},{"key":"2026080312015329668_j_aiht-2025-76-3973_ref_018","doi-asserted-by":"crossref","unstructured":"Karim M, Pohane AA, Lo CW, Einav S, Garhyan J. Chemical inactivation strategies for SARS-CoV-2-infected cells and organoids. STAR Protoc 2024;15:5:102906. doi: 10.1016\/j.xpro.2024.102906","DOI":"10.1016\/j.xpro.2024.102906"},{"key":"2026080312015329668_j_aiht-2025-76-3973_ref_019","doi-asserted-by":"crossref","unstructured":"Bidra AS, Pelletier JS, Westover JB, Frank S, Brown SM, Tessema B. Rapid in-vitro inactivation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) using povidone-iodine oral antiseptic rinse. J Prosthodont 2020;29:529\u201333. doi: 10.1111\/jopr.13209","DOI":"10.1111\/jopr.13209"},{"key":"2026080312015329668_j_aiht-2025-76-3973_ref_020","doi-asserted-by":"crossref","unstructured":"Abraham JP, Plourde BD, Cheng L. Using heat to kill SARS-CoV-2. Rev Med Virol 2020;30(5):e2115. doi: 10.1002\/rmv.2115","DOI":"10.1002\/rmv.2115"},{"key":"2026080312015329668_j_aiht-2025-76-3973_ref_021","doi-asserted-by":"crossref","unstructured":"Pastorino B, Touret F, Gilles M, de Lamballerie X, Charrel RN. Heat inactivation of different types of SARS-CoV-2 samples: what protocols for biosafety, molecular detection and serological diagnostics? Viruses 2020;12(7):735. doi: 10.3390\/v12070735","DOI":"10.3390\/v12070735"},{"key":"2026080312015329668_j_aiht-2025-76-3973_ref_022","unstructured":"Hessling M, Hoenes K, Lingenfelder C. Selection of parameters for thermal coronavirus inactivation - a data-based recommendation. GMS Hyg Infect Control 2020;15:Doc16. doi: 10.3205\/dgkh000351"},{"key":"2026080312015329668_j_aiht-2025-76-3973_ref_023","doi-asserted-by":"crossref","unstructured":"Chen H, Wu R, Xing Y, Du Q, Xue Z, Xi Y, Yang Y, Deng Y, Han Y, Li K, Luan Y, Zhang Y, Wei X, Yu T, Li H, Zhu L, Su S, Lian H, Lu L, Tan C, Zheng H, Chen B, Yu P, Guo Y, Ma C. Influence of different inactivation methods on severe acute respiratory syndrome coronavirus 2 RNA copy number. J Clin Microbiol 2020;58(8):e00958\u201320. doi: 10.1128\/JCM.00958-20","DOI":"10.1128\/JCM.00958-20"},{"key":"2026080312015329668_j_aiht-2025-76-3973_ref_024","unstructured":"World Health Organization (WHO). Laboratory testing strategy recommendations for COVID-19: interim guidance [displayed 24 December 2024]. Available at https:\/\/iris.who.int\/bitstream\/handle\/10665\/331509\/WHO-COVID-19-lab_testing-2020.1-eng.pdf?sequence=1"},{"key":"2026080312015329668_j_aiht-2025-76-3973_ref_025","unstructured":"Tianlong. Viral DNA and RNA extraction kit. Instructions for use [displayed 24 December 2024]. Available at https:\/\/www.medtl.net\/products\/viral-dna-and-rna-extraction-kit.html"},{"key":"2026080312015329668_j_aiht-2025-76-3973_ref_026","unstructured":"GeneFinder\u2122 COVID-19 Plus RealAmp Kit. Instructions for Use. Food and Drug Administration, 2021 [displayed 24 December 2024]. Available at https:\/\/www.fda.gov\/media\/137116\/download"},{"key":"2026080312015329668_j_aiht-2025-76-3973_ref_027","doi-asserted-by":"crossref","unstructured":"Wu ZG, Zheng HY, Gu J, Li F, Lv RL, Deng YY, Xu WZ, Tong YQ. Effects of different temperature and time durations of virus inactivation on results of real-time fluorescence PCR testing of COVID-19 viruses. Curr Med Sci 2020;40:614\u20137. doi: 10.1007\/s11596-020-2224-y","DOI":"10.1007\/s11596-020-2224-y"},{"key":"2026080312015329668_j_aiht-2025-76-3973_ref_028","doi-asserted-by":"crossref","unstructured":"Woldesemayat B, Gebremicael G, Zealiyas K, Yilma A, Adane S, Yimer M, Gutema G, Feleke A, Desta K. Effect of heat inactivation for the detection of severe acute respiratory syndrome-corona virus-2 (SARSCoV-2) with reverse transcription real time polymerase chain reaction (rRT-PCR): evidence from Ethiopian study. BMC Infect Dis 2022;22:163. doi: 10.1186\/s12879-022-07134-7","DOI":"10.1186\/s12879-022-07134-7"},{"key":"2026080312015329668_j_aiht-2025-76-3973_ref_029","doi-asserted-by":"crossref","unstructured":"Kim YI, Casel MAB, Kim SM, Kim SG, Park SJ, Kim EH, Jeong HW, Poo H, Choi YK. Development of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) thermal inactivation method with preservation of diagnostic sensitivity. J Microbiol 2020;58:886\u201391. doi: 10.1007\/s12275-020-0335-6","DOI":"10.1007\/s12275-020-0335-6"},{"key":"2026080312015329668_j_aiht-2025-76-3973_ref_030","doi-asserted-by":"crossref","unstructured":"Fomsgaard AS, Rosenstierne MW. An alternative workflow for molecular detection of SARS-CoV-2 - escape from the NA extraction kit-shortage, Copenhagen, Denmark, March 2020. Euro Surveill 2020;25(14):2000398. doi: 10.2807\/1560-7917.ES.2020.25.14.2000398","DOI":"10.2807\/1560-7917.ES.2020.25.14.2000398"},{"key":"2026080312015329668_j_aiht-2025-76-3973_ref_031","doi-asserted-by":"crossref","unstructured":"Pan Y, Long L, Zhang D, Yuan T, Cui S, Yang P, Wang Q, Ren S. Potential false-negative nucleic acid testing results for severe acute respiratory syndrome coronavirus 2 from thermal inactivation of samples with low viral loads. Clin Chem 2020;66:794\u2013801. doi: 10.1093\/clinchem\/hvaa091","DOI":"10.1093\/clinchem\/hvaa091"},{"key":"2026080312015329668_j_aiht-2025-76-3973_ref_032","doi-asserted-by":"crossref","unstructured":"Zou J, Zhi S, Chen M, Su X, Kang L, Li C, Su X, Zhang S, Ge S, Li W. Heat inactivation decreases the qualitative real-time RT-PCR detection rates of clinical samples with high cycle threshold values in COVID-19. Diagn Microbiol Infect Dis 2020;98(1):115109. doi: 10.1016\/j.diagmicrobio.2020.115109","DOI":"10.1016\/j.diagmicrobio.2020.115109"}],"container-title":["Archives of Industrial Hygiene and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/aiht-2025-76-3973","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T12:02:08Z","timestamp":1785758528000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/aiht-2025-76-3973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":32,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,12,30]]},"published-print":{"date-parts":[[2025,12,1]]}},"alternative-id":["10.2478\/aiht-2025-76-3973"],"URL":"https:\/\/doi.org\/10.2478\/aiht-2025-76-3973","relation":{},"ISSN":["1848-6312"],"issn-type":[{"value":"1848-6312","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,1]]}}}